National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 12769-12770 [2013-04210]

Download as PDF Federal Register / Vol. 78, No. 37 / Monday, February 25, 2013 / Notices Dated: February 19, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–04215 Filed 2–22–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: AIDS and Related Research Integrated Review Group; AIDS Immunology and Pathogenesis Study Section. Date: March 18, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101. Contact Person: Shiv A Prasad, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892, 301–443– 5779, prasads@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Predictors of Substance Use in Young Adulthood. Date: March 18, 2013. Time: 3:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Anna L Riley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3114, MSC 7759, Bethesda, MD 20892, 301–435– 2889, rileyann@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: CounterACT U54 Centers of Excellence. Date: March 19, 2013. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. VerDate Mar<15>2010 17:22 Feb 22, 2013 Jkt 229001 Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 20036. Contact Person: Jonathan K Ivins, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040A, MSC 7806, Bethesda, MD 20892, (301) 594– 1245, ivinsj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Oncological Sciences. Date: March 19–20, 2013. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Inese Z Beitins, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6152, MSC 7892, Bethesda, MD 20892, 301–435– 1034, beitinsi@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: CounterAct U01 Cooperative Agreements. Date: March 19, 2013. Time: 1:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 20036. Contact Person: Jonathan K Ivins, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040A, MSC 7806, Bethesda, MD 20892, (301) 594– 1245, ivinsj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA DA14– 001: U.S.-RUSSIA Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and Co-Morbidities (R21). Date: March 19–20, 2013. Time: 7:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 20036. Contact Person: Hilary D Sigmon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, (301) 594– 6377, sigmonh@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 15, 2013. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2013–04204 Filed 2–22–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 12769 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Vaccine Research Center Board of Scientific Counselors, NIAID. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Allergy and Infectious Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Name of Committee: Vaccine Research Center Board of Scientific Counselors, NIAID. Date: April 29–30, 2013. Closed: 8:30 a.m. to 3:30 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 40, Room 1201/1203, 40 Center Drive, Bethesda, MD 20892. Contact Person: John R Mascola, MD, Deputy Director, Vaccine Research Center, NIAID, NIH, 40 Convent Drive, Bethesda, MD 20892, (301) 496–1852, jmascola@nih.gov. Name of Committee: Vaccine Research Center Board of Scientific Counselors, NIAID. Date: April 29, 2013. Closed: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate personal qualifications and performances, and competence of individual investigators. Place: National Institutes of Health, Building 40, Room 1201/1203, 40 Center Drive, Bethesda, MD 20892. Contact Person: John R. Mascola, MD, Deputy Director, Vaccine Research Center, NIAID, NIH, 40 Convent Drive, Bethesda, MD 20892, (301) 496–1852, jmascola@nih.gov. Name of Committee: Vaccine Research Center Board of Scientific Counselors, NIAID. Date: April 30, 2013. E:\FR\FM\25FEN1.SGM 25FEN1 12770 Federal Register / Vol. 78, No. 37 / Monday, February 25, 2013 / Notices Closed: 8:30 a.m. to 3:30 p.m. Agenda: To review and evaluate personal qualifications and performances, and competence of individual investigators. Place: National Institutes of Health, Building 40, Room 1201/1203, 40 Center Drive, Bethesda, MD 20892, (301) 496–1852. Contact Person: John R. Mascola, MD, Deputy Director, Vaccine Research Center, NIAID, NIH, 40 Convent Drive, Bethesda, MD 20892, (301) 496–1852, jmascola@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: February 19, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–04210 Filed 2–22–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration SAMHSA/CSAP program (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Project: National Outcome Measures (NOMs) for Substance Abuse Prevention—(OMB No. 0930–0230)— Revision This is a revision to the previously OMB approved instrument for the Center for Substance Abuse Prevention’s (CSAP) National Outcome Measures for Substance Abuse Prevention (NOMs). Data are collected from SAMHSA/CSAP grants and contracts where community and participant outcomes are assessed. The analysis of these data helps determine whether progress is being made in achieving SAMHSA/CSAP’s mission. The primary purpose of this system is to promote the use among SAMHSA/CSAP grantees and contractors of common National Outcome Measures recommended by SAMHSA/CSAP with significant input from panels of experts and state representatives. Approval of this information collection will allow SAMHSA to continue to meet Government Number of grantees Number of respondents Performance and Results Modernization Act of 2010 (GPRAMA) reporting requirements that quantify the effects and accomplishments of its discretionary grant programs which are consistent with OMB guidance, and address goals and objectives outlined in the Office of National Drug Control Policy’s Performance Measures of Effectiveness. Note that the only changes is the deletion of one question per instrument, the deletion of prior Fiscal Years, and the PPC program which was not funded. The question being deleted is Has the Service Member experienced any of the following (select all that apply) (a) Deployed in support of combat operations (e.g. Iraq or Afghanistan) (b) Was physically injured during combat operations (c) Developed combat stress symptoms/ difficulties adjusting following deployment, including PTSD, depression, or suicidal thoughts (d) Died or was killed The total annual burden estimate is shown below: Responses per respondent Number of responses Hours/ response Total hours FY 13 Science/Services: Fetal Alcohol ..................................... Capacity: HIV .................................................... SPF SIG ............................................ SPF SIG/Community Level * ............ SPF SIG/Program Level * ................ PFS ................................................... PFS/Community Level * ................... Annual Average ......................... 23 4,800 14,400 3 0.4 5,760 122 35 ........................ ........................ 37 ........................ 217 31,964 ........................ 29,925 9,100 ........................ 37,000 112,889 95,892 ........................ 29,925 27,300 ........................ 37,000 204,517 3 0 1 3 0 1 ........................ 0.4 ........................ 0.4 0.4 ........................ 0.4 ........................ 38,357 ........................ 11,970 10,920 ........................ 14,800 81,807 mstockstill on DSK4VPTVN1PROD with NOTICES * The Strategic Prevention Framework State Incentive Grant (SPF SIG) and Partnerships for Success (PFS) have a three level evaluation: The Grantee, Community and Program Level. The Grantee level data will be pre-populated by SAMHSA. The use of the Community Level instrument is optional as they relate to targeted interventions implemented during the reporting period. At the program level, items will be selected in line with direct services implemented. Written comments and recommendations concerning the proposed information collection should be sent by March 27, 2013 to the SAMHSA Desk Officer at the Office of Information and Regulatory Affairs, Office of Management and Budget (OMB). To ensure timely receipt of comments, and to avoid potential delays in OMB’s receipt and processing of mail sent through the U.S. Postal Service, commenters are encouraged to submit their comments to OMB via email to: VerDate Mar<15>2010 17:22 Feb 22, 2013 Jkt 229001 OIRA_Submission@omb.eop.gov. Although commenters are encouraged to send their comments via email, commenters may also fax their comments to: 202–395–7285. Commenters may also mail them to: Office of Management and Budget, Office of Information and Regulatory PO 00000 Frm 00057 Fmt 4703 Sfmt 9990 Affairs, New Executive Office Building, Room 10102, Washington, DC 20503. Summer King, Statistician. [FR Doc. 2013–04270 Filed 2–22–13; 8:45 am] BILLING CODE 4162–20–P E:\FR\FM\25FEN1.SGM 25FEN1

Agencies

[Federal Register Volume 78, Number 37 (Monday, February 25, 2013)]
[Notices]
[Pages 12769-12770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04210]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Vaccine Research Center Board of Scientific Counselors, NIAID.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Allergy and Infectious Diseases, including consideration 
of personnel qualifications and performance, and the competence of 
individual investigators, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one form 
of identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.

    Name of Committee: Vaccine Research Center Board of Scientific 
Counselors, NIAID.
    Date: April 29-30, 2013.
    Closed: 8:30 a.m. to 3:30 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 40, Room 1201/
1203, 40 Center Drive, Bethesda, MD 20892.
    Contact Person: John R Mascola, MD, Deputy Director, Vaccine 
Research Center, NIAID, NIH, 40 Convent Drive, Bethesda, MD 20892, 
(301) 496-1852, jmascola@nih.gov.

    Name of Committee: Vaccine Research Center Board of Scientific 
Counselors, NIAID.
    Date: April 29, 2013.
    Closed: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performances, and competence of individual investigators.
    Place: National Institutes of Health, Building 40, Room 1201/
1203, 40 Center Drive, Bethesda, MD 20892.
    Contact Person: John R. Mascola, MD, Deputy Director, Vaccine 
Research Center, NIAID, NIH, 40 Convent Drive, Bethesda, MD 20892, 
(301) 496-1852, jmascola@nih.gov.

    Name of Committee: Vaccine Research Center Board of Scientific 
Counselors, NIAID.
    Date: April 30, 2013.

[[Page 12770]]

    Closed: 8:30 a.m. to 3:30 p.m.
    Agenda: To review and evaluate personal qualifications and 
performances, and competence of individual investigators.
    Place: National Institutes of Health, Building 40, Room 1201/
1203, 40 Center Drive, Bethesda, MD 20892, (301) 496-1852.
    Contact Person: John R. Mascola, MD, Deputy Director, Vaccine 
Research Center, NIAID, NIH, 40 Convent Drive, Bethesda, MD 20892, 
(301) 496-1852, jmascola@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 19, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-04210 Filed 2-22-13; 8:45 am]
BILLING CODE 4140-01-P